Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Return on Equity (2021 - 2025)

Historic Return on Equity for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to 0.47%.

  • Relay Therapeutics' Return on Equity fell 100.0% to 0.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.44% for FY2024, which is 400.0% down from last year.
  • According to the latest figures from Q3 2025, Relay Therapeutics' Return on Equity is 0.47%, which was down 100.0% from 0.45% recorded in Q2 2025.
  • Over the past 5 years, Relay Therapeutics' Return on Equity peaked at 0.09% during Q1 2021, and registered a low of 0.5% during Q4 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.44% (2021), whereas its average is 0.4%.
  • Per our database at Business Quant, Relay Therapeutics' Return on Equity plummeted by -4600bps in 2021 and then surged by 2000bps in 2022.
  • Relay Therapeutics' Return on Equity (Quarter) stood at 0.5% in 2021, then skyrocketed by 40bps to 0.3% in 2022, then plummeted by -50bps to 0.45% in 2023, then grew by 7bps to 0.42% in 2024, then decreased by -12bps to 0.47% in 2025.
  • Its Return on Equity was 0.47% in Q3 2025, compared to 0.45% in Q2 2025 and 0.44% in Q1 2025.